State Of Tennessee, Treasury Department Eagle Pharmaceuticals, Inc. Transaction History

State Of Tennessee, Treasury Department

$27.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$17.74 - $31.87 $46,443 - $83,435	-2,618 Reduced 42.53%	3,538 $68,000
Q1 2023 May 12, 2023	SELL	$25.06 - $34.09 $54,856 - $74,623	-2,189 Reduced 26.23%	6,156 $174,000
Q4 2022 Feb 15, 2023	BUY	$24.98 - $39.77 $8,193 - $13,044	328 Added 4.09%	8,345 $244,000
Q3 2022 Jan 26, 2023	BUY	$26.42 - $47.12 $10,303 - $18,376	390 Added 5.11%	8,017 $212,000
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $2,640 - $3,286	-64 Reduced 0.83%	7,627 $339,000
Q1 2022 May 11, 2022	BUY	$44.58 - $52.6 $28,754 - $33,927	645 Added 9.15%	7,691 $381,000
Q4 2021 Feb 15, 2022	BUY	$45.82 - $56.9 $18,648 - $23,158	407 Added 6.13%	7,046 $359,000
Q3 2021 Nov 12, 2021	SELL	$43.79 - $55.78 $17,428 - $22,200	-398 Reduced 5.66%	6,639 $371,000
Q2 2021 Aug 11, 2021	SELL	$36.86 - $44.5 $995 - $1,201	-27 Reduced 0.38%	7,037 $301,000
Q1 2021 May 10, 2021	BUY	$40.32 - $50.97 $16,289 - $20,591	404 Added 6.07%	7,064 $295,000
Q4 2020 Feb 09, 2021	BUY	$41.72 - $51.34 $23,738 - $29,212	569 Added 9.34%	6,660 $310,000
Q2 2020 Aug 13, 2020	SELL	$43.24 - $55.02 $22,657 - $28,830	-524 Reduced 7.92%	6,091 $292,000
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $12,201 - $21,324	-355 Reduced 5.09%	6,615 $304,000
Q4 2019 Feb 06, 2020	SELL	$54.32 - $64.31 $61,272 - $72,541	-1,128 Reduced 13.93%	6,970 $419,000
Q3 2019 Oct 30, 2019	BUY	$53.25 - $59.98 $29,394 - $33,108	552 Added 7.32%	8,098 $458,000
Q2 2019 Aug 12, 2019	SELL	$46.61 - $58.45 $7,224 - $9,059	-155 Reduced 2.01%	7,546 $420,000
Q1 2019 May 13, 2019	SELL	$38.66 - $51.82 $8,079 - $10,830	-209 Reduced 2.64%	7,701 $389,000
Q4 2018 Feb 11, 2019	BUY	$36.72 - $67.73 $68,996 - $127,264	1,879 Added 31.16%	7,910 $319,000
Q3 2018 Nov 13, 2018	BUY	$66.65 - $83.86 $16,862 - $21,216	253 Added 4.38%	6,031 $418,000
Q2 2018 Aug 14, 2018	SELL	$51.25 - $76.62 $10,352 - $15,477	-202 Reduced 3.38%	5,778 $437,000
Q1 2018 May 11, 2018	SELL	$52.16 - $66.86 $19,247 - $24,671	-369 Reduced 5.81%	5,980 $315,000
Q4 2017 Feb 12, 2018	SELL	$49.6 - $60.87 $34,273 - $42,061	-691 Reduced 9.82%	6,349 $339,000
Q3 2017 Nov 01, 2017	BUY	$46.62 - $60.36 $328,204 - $424,934	7,040	7,040 $420,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Account